Press

About Re:Cognition Health

Re:Cognition Health is a leading brain and mind health specialist, providing advanced diagnostics, treatment, and support for conditions such as Alzheimer’s, dementia, concussion, and cognitive disorders. Its expert clinicians use cutting-edge technology, clinical trials, and personalized care plans to deliver early, accurate diagnoses and effective interventions. With a focus on improving quality of life, Re:Cognition Health offers multidisciplinary support for patients and families, helping people understand symptoms, access the latest treatments, and manage long-term brain health with confidence.

A global leader in Alzheimer’s Disease research and treatment, Re:Cognition Health has been at the forefront of advancing treatments to slow the progression of the disease, from the early stages of clinical trials through FDA approvals and now treatment administration. It holds the distinction of being the first center in Europe to deliver amyloid-targeting therapies (ATT) to patients in a clinical setting; its clinical team is extremely experienced in these treatments, having administered more than 11,500 doses of ATT in the United States and the United Kingdom.

Re:Cognition Health By the Numbers

• Founded in the UK in 2011, expanded to the US in 2018
• 4 centers in the US
• 200+ employees
• 10,600+ patients treated

Meet the Experts

Dr. Emer MacSweeney BSc (Hons), MBBS, MRCP, FRCR 
Co-Founder & CEO of Re:Cognition Health’s Brain and Mind Clinics, UK & USA

Dr. MacSweeney, a Consultant Interventional Neuro-Radiologist, is a world-renowned expert on the available treatments for Alzheimer’s and has been involved from the early days of clinical trials in both the UK and the US. She was the first clinician in Europe to administer Amyloid Targeting Therapy (ATT) drugs to patients outside of a clinical trial, and Re:Cognition Health is one of, if not the, biggest providers of ATT medications in Europe.

She co-founded Re:Cognition Health in 2011 to provide a specialist service for accurate diagnosis and access to the latest treatments for progressive neurodegenerative and neurodevelopmental conditions and traumatic brain injury.

Dr. MacSweeney and Re:Cognition Health’s expertise has been recognized with more than 40 prestigious and international accolades, including:

• Diagnostics Provider of the Year at the 2025 HealthInvestor Awards
• Winner – Best in Healthcare Outcomes, LaingBuisson 2025
• Leaders in Law, Cognitive Health Expert of the Year 2024/25
• Global 100 2023 Best Health Research Company of the Year UK 2023
• EY Entrepreneur of the Year Winner- Societal Impact 2019 (London and South England)
• KPMG Entrepreneur of the Year Winner 2016

Tom S. Dent
Executive Chairman

Tom is a vision and values-based leader having built credibility across multiple stakeholders in the US and UK. Dent is also the Chairman/CEO of urgent care company, Urgent Team, and the Lead Director for HealthStream (NASDQ), a leading provider of workforce, patient experience, and provider solutions. Dent co-founded PhyCor (NASDQ), the pioneer of the Physician Practice/IPA Management industry. His previous leadership roles include international diagnostic imaging, managed care operations, hospital management and healthcare M&A. Dent was a founding Director of Healthcare Realty Trust (NYSE-HR) and earned a B.S. Degree from Mississippi State University and a Master’s Degree from George Washington University.

As Seen in

Emer MacSweeney TEDTalk: CTE – The Silent Killer in Contact Sports

The Brain and Mind Experts Podcast

Blog & Resources